Retirement Planning Company of New England’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$287K Sell
4,438
-124
-3% -$6.79K 0.1% 211
2026
Q1
$239K Sell
4,562
-73
-2% -$3.71K 0.1% 221
2025
Q4
$237K Buy
+4,635
New +$214K 0.1% 222
2025
Q1
Sell
-6,894
Closed -$228K 237
2024
Q4
$228K Sell
6,894
-610
-8% -$23K 0.11% 209
2024
Q3
$280K Buy
7,504
+134
+2% +$4.89K 0.14% 178
2024
Q2
$247K Sell
7,370
-396
-5% -$13.3K 0.13% 180
2024
Q1
$278K Buy
7,766
+11
+0.1% +$381 0.15% 176
2023
Q4
$255K Buy
+7,755
New +$208K 0.12% 185
2023
Q3
Sell
-8,217
Closed -$259K 227
2023
Q2
$259K Buy
8,217
+169
+2% +$5.25K 0.15% 174
2023
Q1
$219K Buy
8,048
+248
+3% +$7.49K 0.13% 196
2022
Q4
$237K Sell
7,800
-418
-5% -$12.6K 0.15% 179
2022
Q3
$247K Buy
8,218
+502
+7% +$15.9K 0.18% 167
2022
Q2
$213K Buy
+7,716
New +$220K 0.15% 192
2022
Q1
Sell
-3,338
Closed -$140K 743
2021
Q4
$140K Buy
+3,338
New +$149K 0.07% 264

Other funds holding SBIO

Retirement Planning Company of New England's SBIO Position: Q2 2026 in Review

Retirement Planning Company of New England reduced its ALPS Medical Breakthroughs ETF (SBIO) stake by 2.7% in Q2 2026, selling an estimated $6.79K and leaving 4,438 shares worth $287K. The position accounts for 0.1% of the portfolio, ranked #211.

Retirement Planning Company of New England first reported a position in SBIO in Q4 2021 and has held it in 14 quarters since. 47 funds tracked by Wall St. Rank hold SBIO as of Q2 2026.

  • Retirement Planning Company of New England held 4,438 shares of ALPS Medical Breakthroughs ETF worth $287K as of Q2 2026.
  • Retirement Planning Company of New England sold 124 ALPS Medical Breakthroughs ETF shares in Q2 2026, an estimated $6.79K.
  • ALPS Medical Breakthroughs ETF made up 0.1% of Retirement Planning Company of New England's portfolio in Q2 2026, its #211 holding.
  • Retirement Planning Company of New England first reported a position in ALPS Medical Breakthroughs ETF in Q4 2021 and has held it in 14 quarters since.
  • 47 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q2 2026.

Based on Retirement Planning Company of New England's 13F filing for Q2 2026, filed 30 Jul 2026.